← back to search

Karmela K Chan

Hospital for Special Surgery ·
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Colorectal Cancer Treatments and Studies, and Immune cells in cancer.
h-index
17
citations
1,125
works
49
NIH funding
primary concept
email

Recent publications

Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study
Lara D. Veeken 2024cited by 10position: middledoi
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis
Arthritis Care & Research 2023cited by 99position: middledoi
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
Annals of the Rheumatic Diseases 2023cited by 71position: middledoi
Clonally expanded CD38 <sup>hi</sup> cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis
Science Immunology 2023cited by 62position: middledoi
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis
Arthritis & Rheumatology 2023cited by 60position: middledoi
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
The Lancet Respiratory Medicine 2022cited by 196position: middledoi
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
Journal for ImmunoTherapy of Cancer 2022cited by 57position: middledoi
Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study
Journal for ImmunoTherapy of Cancer 2021cited by 27position: lastdoi
Autoimmune complications of immunotherapy: pathophysiology and management
BMJ 2020cited by 123position: firstdoi
Checkpoint Inhibitor–Associated Arthritis
JCR Journal of Clinical Rheumatology 2020cited by 74position: middledoi
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature
The Oncologist 2019cited by 68position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Anne R. Bass · Hospital for Special Surgery8 papers (2019–2024)Nilasha Ghosh · Hospital for Special Surgery4 papers (2020–2024)Michael A. Postow · Memorial Sloan Kettering Cancer Center3 papers (2019–2023)Deanna Jannat‐Khah · Hospital for Special Surgery3 papers (2022–2024) · 2 papers (2023–2023)Pankti Reid · University of Chicago2 papers (2021–2023)Jeffrey A. Sparks · Harvard University2 papers (2023–2023)Carlos A. Aude · Johns Hopkins University2 papers (2023–2023)Laura C. Cappelli · Apple (Israel)2 papers (2020–2023) · 1 papers (2023–2023)David Fernández · Hospital for Special Surgery1 papers (2019–2019)Cynthia M. Magro · Cornell University1 papers (2019–2019)Bridget Jivanelli · Hospital for Special Surgery1 papers (2020–2020)Michael D. Tiongson · University of Rochester Medical Center1 papers (2020–2020)Garrett S. Dunlap · Harvard Stem Cell Institute1 papers (2023–2023)Ashish Saxena · Cornell University1 papers (2024–2024)Divya Rajesh · Hospital for Special Surgery1 papers (2023–2023)A. Helena Jonsson · Harvard University1 papers (2023–2023)G. Vitone · Hospital for Special Surgery1 papers (2022–2022)Quan‐Zhen Li · Guangdong University of Technology1 papers (2022–2022)